142.05
2.18 (1.56%)
| Previous Close | 139.87 |
| Open | 139.35 |
| Volume | 839,174 |
| Avg. Volume (3M) | 770,220 |
| Market Cap | 7,630,066,688 |
| Price / Sales | 3.42 |
| Price / Book | 9.18 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2026 |
| Profit Margin | -23.25% |
| Operating Margin (TTM) | 21.69% |
| Diluted EPS (TTM) | -5.45 |
| Quarterly Revenue Growth (YOY) | 9.50% |
| Quarterly Earnings Growth (YOY) | -7.50% |
| Total Debt/Equity (MRQ) | 72.01% |
| Current Ratio (MRQ) | 2.17 |
| Operating Cash Flow (TTM) | 181.70 M |
| Levered Free Cash Flow (TTM) | 139.68 M |
| Return on Assets (TTM) | 1.32% |
| Return on Equity (TTM) | -25.07% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Masimo Corporation | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 3.0 |
| Insider Activity | -3.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.5 |
| Average | -0.30 |
|
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 7.88% |
| % Held by Institutions | 101.46% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Politan Capital Management Lp | 30 Sep 2025 | 4,589,648 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 200.00 (BTIG, 40.80%) | Buy |
| Median | 181.00 (27.42%) | |
| Low | 162.00 (B of A Securities, 14.04%) | Hold |
| Average | 181.00 (27.42%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 144.65 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BTIG | 04 Dec 2025 | 200.00 (40.80%) | Buy | 142.26 |
| 24 Nov 2025 | 198.00 (39.39%) | Buy | 145.62 | |
| B of A Securities | 17 Nov 2025 | 162.00 (14.04%) | Hold | 147.03 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| SAMPATH ANAND | - | 137.67 | -18,680 | -2,571,676 |
| Aggregate Net Quantity | -18,680 | |||
| Aggregate Net Value ($) | -2,571,676 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 137.67 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SAMPATH ANAND | Officer | 28 Jan 2026 | Automatic sell (-) | 18,680 | 137.67 | 2,571,676 |
| SAMPATH ANAND | Officer | 28 Jan 2026 | Option execute | 30,000 | - | - |
| Date | Type | Details |
|---|---|---|
| 12 Jan 2026 | Announcement | Masimo Announces Select Preliminary 2025 Financial Results |
| 07 Jan 2026 | Announcement | Masimo to Present in the J.P. Morgan 2026 Healthcare Conference |
| 03 Dec 2025 | Announcement | Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth |
| 18 Nov 2025 | Announcement | Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case |
| 14 Nov 2025 | Announcement | Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |